- Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
- Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
- Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
- Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
- Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
- Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
- Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
- Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
- Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
- Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
More ▼
Key statistics
On Friday, Eton Pharmaceuticals Inc (ETON:NMQ) closed at 3.55, 46.69% above the 52 week low of 2.42 set on Jul 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.74 |
---|---|
High | 3.74 |
Low | 3.55 |
Bid | 1.44 |
Offer | 3.76 |
Previous close | 3.55 |
Average volume | 58.18k |
---|---|
Shares outstanding | 25.69m |
Free float | 24.30m |
P/E (TTM) | 104.94 |
Market cap | 91.20m USD |
EPS (TTM) | 0.0338 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼